Loading…

The effect of N-acetylcysteine (NAC) on human cognition – A systematic review

•Oxidation and neuroinflammation modulate cognition through a variety of vectors.•NAC mitigates the cognitive effects of neuroinflammation in animals.•Evidence that NAC can modulate human cognition is promising but inconsistent.•Combined antioxidants are effective, but the specific contribution of N...

Full description

Saved in:
Bibliographic Details
Published in:Neuroscience and biobehavioral reviews 2017-07, Vol.78, p.44-56
Main Authors: Skvarc, David R., Dean, Olivia M., Byrne, Linda K., Gray, Laura, Lane, Stephen, Lewis, Matthew, Fernandes, Brisa S., Berk, Michael, Marriott, Andrew
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c437t-3efdba1ee44398a690de419c4b4304f9c1e8444f21ed5d7d772686cdbe5a53143
cites cdi_FETCH-LOGICAL-c437t-3efdba1ee44398a690de419c4b4304f9c1e8444f21ed5d7d772686cdbe5a53143
container_end_page 56
container_issue
container_start_page 44
container_title Neuroscience and biobehavioral reviews
container_volume 78
creator Skvarc, David R.
Dean, Olivia M.
Byrne, Linda K.
Gray, Laura
Lane, Stephen
Lewis, Matthew
Fernandes, Brisa S.
Berk, Michael
Marriott, Andrew
description •Oxidation and neuroinflammation modulate cognition through a variety of vectors.•NAC mitigates the cognitive effects of neuroinflammation in animals.•Evidence that NAC can modulate human cognition is promising but inconsistent.•Combined antioxidants are effective, but the specific contribution of NAC is unknown.•Further exploration of NAC’s ability to modify cognitive change is warranted. Oxidative stress, neuroinflammation and neurogenesis are commonly implicated as cognitive modulators across a range of disorders. N-acetylcysteine (NAC) is a glutathione precursor with potent antioxidant, pro-neurogenesis and anti-inflammatory properties and a favourable safety profile. A systematic review of the literature specifically examining the effect of NAC administration on human cognition revealed twelve suitable articles for inclusion: four examining Alzheimer's disease; three examining healthy participants; two examining physical trauma; one examining bipolar disorder, one examining schizophrenia, and one examining ketamine-induced psychosis. Heterogeneity of studies, insufficiently powered studies, infrequency of cognition as a primary outcome, heterogeneous methodologies, formulations, co-administered treatments, administration regimes, and assessment confounded the drawing of firm conclusions. The available data suggested statistically significant cognitive improvements following NAC treatment, though the paucity of NAC-specific research makes it difficult to determine if this effect is meaningful. While NAC may have a positive cognitive effect in a variety of contexts; larger, targeted studies are warranted, specifically evaluating its role in other clinical disorders with cognitive sequelae resulting from oxidative stress and neuroinflammation.
doi_str_mv 10.1016/j.neubiorev.2017.04.013
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1891888126</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0149763416303980</els_id><sourcerecordid>1891888126</sourcerecordid><originalsourceid>FETCH-LOGICAL-c437t-3efdba1ee44398a690de419c4b4304f9c1e8444f21ed5d7d772686cdbe5a53143</originalsourceid><addsrcrecordid>eNqFkEtOwzAQhi0EgvK4AngJiwQ7nsTOsqp4SQg2sLYce0JdNQnECag77sANOQmuWtiyGo30_fP4CDnjLOWMF5eLtMWx8l2P72nGuEwZpIyLHTLhSopE5pnaJRPGoUxkIeCAHIawYIxlTOT75CBTIBQUxYQ8Ps2RYl2jHWhX04fEWBxWS7sKA_oW6fnDdHZBu5bOx8a01HYvrR987L8_v-iUhjXXmMFbGk_x-HFM9mqzDHiyrUfk-frqaXab3D_e3M2m94kFIYdEYO0qwxEBRKlMUTKHwEsLFQgGdWk5KgCoM44ud9JJmRWqsK7C3OSCgzgi55u5r333NmIYdOODxeXStNiNQXNVcqUUz4qIyg1q-y6EHmv92vvG9CvNmV7b1Av9Z1OvbWoGOtqMydPtkrFq0P3lfvVFYLoBML4a3-91sB5bi8730ah2nf93yQ_mNIqX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1891888126</pqid></control><display><type>article</type><title>The effect of N-acetylcysteine (NAC) on human cognition – A systematic review</title><source>ScienceDirect Freedom Collection</source><creator>Skvarc, David R. ; Dean, Olivia M. ; Byrne, Linda K. ; Gray, Laura ; Lane, Stephen ; Lewis, Matthew ; Fernandes, Brisa S. ; Berk, Michael ; Marriott, Andrew</creator><creatorcontrib>Skvarc, David R. ; Dean, Olivia M. ; Byrne, Linda K. ; Gray, Laura ; Lane, Stephen ; Lewis, Matthew ; Fernandes, Brisa S. ; Berk, Michael ; Marriott, Andrew</creatorcontrib><description>•Oxidation and neuroinflammation modulate cognition through a variety of vectors.•NAC mitigates the cognitive effects of neuroinflammation in animals.•Evidence that NAC can modulate human cognition is promising but inconsistent.•Combined antioxidants are effective, but the specific contribution of NAC is unknown.•Further exploration of NAC’s ability to modify cognitive change is warranted. Oxidative stress, neuroinflammation and neurogenesis are commonly implicated as cognitive modulators across a range of disorders. N-acetylcysteine (NAC) is a glutathione precursor with potent antioxidant, pro-neurogenesis and anti-inflammatory properties and a favourable safety profile. A systematic review of the literature specifically examining the effect of NAC administration on human cognition revealed twelve suitable articles for inclusion: four examining Alzheimer's disease; three examining healthy participants; two examining physical trauma; one examining bipolar disorder, one examining schizophrenia, and one examining ketamine-induced psychosis. Heterogeneity of studies, insufficiently powered studies, infrequency of cognition as a primary outcome, heterogeneous methodologies, formulations, co-administered treatments, administration regimes, and assessment confounded the drawing of firm conclusions. The available data suggested statistically significant cognitive improvements following NAC treatment, though the paucity of NAC-specific research makes it difficult to determine if this effect is meaningful. While NAC may have a positive cognitive effect in a variety of contexts; larger, targeted studies are warranted, specifically evaluating its role in other clinical disorders with cognitive sequelae resulting from oxidative stress and neuroinflammation.</description><identifier>ISSN: 0149-7634</identifier><identifier>EISSN: 1873-7528</identifier><identifier>DOI: 10.1016/j.neubiorev.2017.04.013</identifier><identifier>PMID: 28438466</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Acetylcysteine ; Antioxidant ; Antioxidants ; Cognition ; dementia ; Executive function ; Glutathione ; Humans ; Inflammation ; N-acetylcysteine ; Neuropsychology ; Oxidative Stress ; Post-operative cognitive dysfunction</subject><ispartof>Neuroscience and biobehavioral reviews, 2017-07, Vol.78, p.44-56</ispartof><rights>2017</rights><rights>Crown Copyright © 2017. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c437t-3efdba1ee44398a690de419c4b4304f9c1e8444f21ed5d7d772686cdbe5a53143</citedby><cites>FETCH-LOGICAL-c437t-3efdba1ee44398a690de419c4b4304f9c1e8444f21ed5d7d772686cdbe5a53143</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28438466$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Skvarc, David R.</creatorcontrib><creatorcontrib>Dean, Olivia M.</creatorcontrib><creatorcontrib>Byrne, Linda K.</creatorcontrib><creatorcontrib>Gray, Laura</creatorcontrib><creatorcontrib>Lane, Stephen</creatorcontrib><creatorcontrib>Lewis, Matthew</creatorcontrib><creatorcontrib>Fernandes, Brisa S.</creatorcontrib><creatorcontrib>Berk, Michael</creatorcontrib><creatorcontrib>Marriott, Andrew</creatorcontrib><title>The effect of N-acetylcysteine (NAC) on human cognition – A systematic review</title><title>Neuroscience and biobehavioral reviews</title><addtitle>Neurosci Biobehav Rev</addtitle><description>•Oxidation and neuroinflammation modulate cognition through a variety of vectors.•NAC mitigates the cognitive effects of neuroinflammation in animals.•Evidence that NAC can modulate human cognition is promising but inconsistent.•Combined antioxidants are effective, but the specific contribution of NAC is unknown.•Further exploration of NAC’s ability to modify cognitive change is warranted. Oxidative stress, neuroinflammation and neurogenesis are commonly implicated as cognitive modulators across a range of disorders. N-acetylcysteine (NAC) is a glutathione precursor with potent antioxidant, pro-neurogenesis and anti-inflammatory properties and a favourable safety profile. A systematic review of the literature specifically examining the effect of NAC administration on human cognition revealed twelve suitable articles for inclusion: four examining Alzheimer's disease; three examining healthy participants; two examining physical trauma; one examining bipolar disorder, one examining schizophrenia, and one examining ketamine-induced psychosis. Heterogeneity of studies, insufficiently powered studies, infrequency of cognition as a primary outcome, heterogeneous methodologies, formulations, co-administered treatments, administration regimes, and assessment confounded the drawing of firm conclusions. The available data suggested statistically significant cognitive improvements following NAC treatment, though the paucity of NAC-specific research makes it difficult to determine if this effect is meaningful. While NAC may have a positive cognitive effect in a variety of contexts; larger, targeted studies are warranted, specifically evaluating its role in other clinical disorders with cognitive sequelae resulting from oxidative stress and neuroinflammation.</description><subject>Acetylcysteine</subject><subject>Antioxidant</subject><subject>Antioxidants</subject><subject>Cognition</subject><subject>dementia</subject><subject>Executive function</subject><subject>Glutathione</subject><subject>Humans</subject><subject>Inflammation</subject><subject>N-acetylcysteine</subject><subject>Neuropsychology</subject><subject>Oxidative Stress</subject><subject>Post-operative cognitive dysfunction</subject><issn>0149-7634</issn><issn>1873-7528</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqFkEtOwzAQhi0EgvK4AngJiwQ7nsTOsqp4SQg2sLYce0JdNQnECag77sANOQmuWtiyGo30_fP4CDnjLOWMF5eLtMWx8l2P72nGuEwZpIyLHTLhSopE5pnaJRPGoUxkIeCAHIawYIxlTOT75CBTIBQUxYQ8Ps2RYl2jHWhX04fEWBxWS7sKA_oW6fnDdHZBu5bOx8a01HYvrR987L8_v-iUhjXXmMFbGk_x-HFM9mqzDHiyrUfk-frqaXab3D_e3M2m94kFIYdEYO0qwxEBRKlMUTKHwEsLFQgGdWk5KgCoM44ud9JJmRWqsK7C3OSCgzgi55u5r333NmIYdOODxeXStNiNQXNVcqUUz4qIyg1q-y6EHmv92vvG9CvNmV7b1Av9Z1OvbWoGOtqMydPtkrFq0P3lfvVFYLoBML4a3-91sB5bi8730ah2nf93yQ_mNIqX</recordid><startdate>201707</startdate><enddate>201707</enddate><creator>Skvarc, David R.</creator><creator>Dean, Olivia M.</creator><creator>Byrne, Linda K.</creator><creator>Gray, Laura</creator><creator>Lane, Stephen</creator><creator>Lewis, Matthew</creator><creator>Fernandes, Brisa S.</creator><creator>Berk, Michael</creator><creator>Marriott, Andrew</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201707</creationdate><title>The effect of N-acetylcysteine (NAC) on human cognition – A systematic review</title><author>Skvarc, David R. ; Dean, Olivia M. ; Byrne, Linda K. ; Gray, Laura ; Lane, Stephen ; Lewis, Matthew ; Fernandes, Brisa S. ; Berk, Michael ; Marriott, Andrew</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c437t-3efdba1ee44398a690de419c4b4304f9c1e8444f21ed5d7d772686cdbe5a53143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acetylcysteine</topic><topic>Antioxidant</topic><topic>Antioxidants</topic><topic>Cognition</topic><topic>dementia</topic><topic>Executive function</topic><topic>Glutathione</topic><topic>Humans</topic><topic>Inflammation</topic><topic>N-acetylcysteine</topic><topic>Neuropsychology</topic><topic>Oxidative Stress</topic><topic>Post-operative cognitive dysfunction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Skvarc, David R.</creatorcontrib><creatorcontrib>Dean, Olivia M.</creatorcontrib><creatorcontrib>Byrne, Linda K.</creatorcontrib><creatorcontrib>Gray, Laura</creatorcontrib><creatorcontrib>Lane, Stephen</creatorcontrib><creatorcontrib>Lewis, Matthew</creatorcontrib><creatorcontrib>Fernandes, Brisa S.</creatorcontrib><creatorcontrib>Berk, Michael</creatorcontrib><creatorcontrib>Marriott, Andrew</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuroscience and biobehavioral reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Skvarc, David R.</au><au>Dean, Olivia M.</au><au>Byrne, Linda K.</au><au>Gray, Laura</au><au>Lane, Stephen</au><au>Lewis, Matthew</au><au>Fernandes, Brisa S.</au><au>Berk, Michael</au><au>Marriott, Andrew</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of N-acetylcysteine (NAC) on human cognition – A systematic review</atitle><jtitle>Neuroscience and biobehavioral reviews</jtitle><addtitle>Neurosci Biobehav Rev</addtitle><date>2017-07</date><risdate>2017</risdate><volume>78</volume><spage>44</spage><epage>56</epage><pages>44-56</pages><issn>0149-7634</issn><eissn>1873-7528</eissn><abstract>•Oxidation and neuroinflammation modulate cognition through a variety of vectors.•NAC mitigates the cognitive effects of neuroinflammation in animals.•Evidence that NAC can modulate human cognition is promising but inconsistent.•Combined antioxidants are effective, but the specific contribution of NAC is unknown.•Further exploration of NAC’s ability to modify cognitive change is warranted. Oxidative stress, neuroinflammation and neurogenesis are commonly implicated as cognitive modulators across a range of disorders. N-acetylcysteine (NAC) is a glutathione precursor with potent antioxidant, pro-neurogenesis and anti-inflammatory properties and a favourable safety profile. A systematic review of the literature specifically examining the effect of NAC administration on human cognition revealed twelve suitable articles for inclusion: four examining Alzheimer's disease; three examining healthy participants; two examining physical trauma; one examining bipolar disorder, one examining schizophrenia, and one examining ketamine-induced psychosis. Heterogeneity of studies, insufficiently powered studies, infrequency of cognition as a primary outcome, heterogeneous methodologies, formulations, co-administered treatments, administration regimes, and assessment confounded the drawing of firm conclusions. The available data suggested statistically significant cognitive improvements following NAC treatment, though the paucity of NAC-specific research makes it difficult to determine if this effect is meaningful. While NAC may have a positive cognitive effect in a variety of contexts; larger, targeted studies are warranted, specifically evaluating its role in other clinical disorders with cognitive sequelae resulting from oxidative stress and neuroinflammation.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>28438466</pmid><doi>10.1016/j.neubiorev.2017.04.013</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0149-7634
ispartof Neuroscience and biobehavioral reviews, 2017-07, Vol.78, p.44-56
issn 0149-7634
1873-7528
language eng
recordid cdi_proquest_miscellaneous_1891888126
source ScienceDirect Freedom Collection
subjects Acetylcysteine
Antioxidant
Antioxidants
Cognition
dementia
Executive function
Glutathione
Humans
Inflammation
N-acetylcysteine
Neuropsychology
Oxidative Stress
Post-operative cognitive dysfunction
title The effect of N-acetylcysteine (NAC) on human cognition – A systematic review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T11%3A15%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20N-acetylcysteine%20(NAC)%20on%20human%20cognition%20%E2%80%93%20A%20systematic%20review&rft.jtitle=Neuroscience%20and%20biobehavioral%20reviews&rft.au=Skvarc,%20David%20R.&rft.date=2017-07&rft.volume=78&rft.spage=44&rft.epage=56&rft.pages=44-56&rft.issn=0149-7634&rft.eissn=1873-7528&rft_id=info:doi/10.1016/j.neubiorev.2017.04.013&rft_dat=%3Cproquest_cross%3E1891888126%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c437t-3efdba1ee44398a690de419c4b4304f9c1e8444f21ed5d7d772686cdbe5a53143%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1891888126&rft_id=info:pmid/28438466&rfr_iscdi=true